Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LANTIT: Forced Titration of Lantus in T2DM
NCT00701831Phase 4Completed
- Sponsor
- Sanofi
- Start
- May 2008
- Primary completion
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Primary endpoints: Glycated Hemoglobin A1c at 6 months, Fasting Blood Glucose at 6 months and 3 more. Started May 2008; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00701831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00701831.